Dock derived compound against laminin receptor (37 LR) and uses thereof
申请人:Purdue Research Foundation
公开号:US11022604B2
公开(公告)日:2021-06-01
An in silico screening method generated compounds that are against laminin receptor 37LR and their anti-cancer functions in prostate cancer cell lines are disclosed herein. A group of derivatives based on the hit compound from the in silico screening are synthesized and tested with improved IC50 value that can have relevant clinical use for prostate cancer or osteoarthritis.
200. The preparation of some 2,3-dihydro-1,4-benzoxazepin-5(4H)-ones and related compounds
作者:D. Huckle、I. M. Lockhart、M. Wright
DOI:10.1039/jr9650001137
日期:——
N-SUBSTITUTED BENzOYL INDOLES AS ESTROGENIC AGENTS
申请人:AMERICAN HOME PRODUCTS CORPORATION
公开号:EP1159268A1
公开(公告)日:2001-12-05
Dock Derived Compound against Laminin Receptor (37 LR) and Uses thereof
申请人:Purdue Research Foundation
公开号:US20200064334A1
公开(公告)日:2020-02-27
An in silico screening method generated compounds that are against laminin receptor 37LR and their anti-cancer functions in prostate cancer cell lines are disclosed herein. A group of derivatives based on the hit compound from the in silico screening are synthesized and tested with improved IC
50
value that can have relevant clinical use for prostate cancer or osteoarthritis.